{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T13:54:01Z","timestamp":1762610041301,"version":"build-2065373602"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,8]]},"DOI":"10.7759\/cureus.96367","type":"journal-article","created":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T13:47:21Z","timestamp":1762609641000},"source":"Crossref","is-referenced-by-count":0,"title":["Kappa Light Chain-Restricted Multiple Myeloma with Biopsy-Proven Cast Nephropathy and Negative Bence\u2013Jones Proteinuria: A Rare Clinical Presentation"],"prefix":"10.7759","author":[{"given":"Hamesh","family":"Gundala Raja","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manoj","family":"Sivakumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loveleen K","family":"Johal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumair","family":"Ali Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatimah","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sjbs.2023.103920","article-title":"An overview of multiple myeloma: a monoclonal plasma cell malignancy's diagnosis, management, and treatment modalities","volume":"31","author":"Abduh MS","year":"2024","unstructured":"Abduh MS. An overview of multiple myeloma: a monoclonal plasma cell malignancy's diagnosis, management, and treatment modalities. Saudi J Biol Sci. 2024, 31:103920. 10.1016\/j.sjbs.2023.103920","journal-title":"Saudi J Biol Sci"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26590","article-title":"Multiple myeloma: 2022 update on diagnosis, risk stratification, and management","volume":"97","author":"Rajkumar SV","year":"2022","unstructured":"Rajkumar SV. Multiple myeloma: 2022 update on diagnosis, risk stratification, and management. Am J Hematol. 2022, 97:1086-107. 10.1002\/ajh.26590","journal-title":"Am J Hematol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.14740\/wjon1780","article-title":"Multiple myeloma: a review of the literature and a case report highlighting the immunocompromised state of myeloma patients","volume":"15","author":"Nightingale B","year":"2024","unstructured":"Nightingale B, Decker M, Ryan R, et al.. Multiple myeloma: a review of the literature and a case report highlighting the immunocompromised state of myeloma patients. World J Oncol. 2024, 15:348-54. 10.14740\/wjon1780","journal-title":"World J Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfy065","article-title":"Treatment of multiple myeloma with renal involvement: the nephrologist's view","volume":"11","author":"Fav\u00e0 A","year":"2018","unstructured":"Fav\u00e0 A, Fulladosa X, Montero N, Draibe J, Torras J, Gom\u00e0 M, Cruzado JM. Treatment of multiple myeloma with renal involvement: the nephrologist's view. Clin Kidney J. 2018, 11:777-85. 10.1093\/ckj\/sfy065","journal-title":"Clin Kidney J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-020-0295-4","article-title":"Serum free light chain level at diagnosis in myeloma cast nephropathy-a multicentre study","volume":"10","author":"Yadav P","year":"2020","unstructured":"Yadav P, Sathick IJ, Leung N, Brown EE, Cook M, Sanders PW, Cockwell P. Serum free light chain level at diagnosis in myeloma cast nephropathy-a multicentre study. Blood Cancer J. 2020, 10:28. 10.1038\/s41408-020-0295-4","journal-title":"Blood Cancer J"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-024-03717-5","article-title":"Kidney function in newly diagnosed myeloma patients: factors associated with kidney impairment and recovery","volume":"25","author":"Cesar BN","year":"2024","unstructured":"Cesar BN, Braga WM, Hamerschlak N, Junior MS. Kidney function in newly diagnosed myeloma patients: factors associated with kidney impairment and recovery. BMC Nephrol. 2024, 25:344. 10.1186\/s12882-024-03717-5","journal-title":"BMC Nephrol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.4143\/crt.2022.952","article-title":"Cyclophosphamide, bortezomib, and dexamethasone consolidation in patients with multiple myeloma after stem cell transplantation: the KMM130 study","volume":"55","author":"Jung J","year":"2023","unstructured":"Jung J, Kim K, Jung SH, et al.. Cyclophosphamide, bortezomib, and dexamethasone consolidation in patients with multiple myeloma after stem cell transplantation: the KMM130 study. Cancer Res Treat. 2023, 55:693-703. 10.4143\/crt.2022.952","journal-title":"Cancer Res Treat"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/425069-kappa-light-chain-restricted-multiple-myeloma-with-biopsy-proven-cast-nephropathy-and-negative-bence-jones-proteinuria-a-rare-clinical-presentation","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T13:47:22Z","timestamp":1762609642000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/425069-kappa-light-chain-restricted-multiple-myeloma-with-biopsy-proven-cast-nephropathy-and-negative-bence-jones-proteinuria-a-rare-clinical-presentation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,8]]},"references-count":7,"URL":"https:\/\/doi.org\/10.7759\/cureus.96367","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,8]]}}}